[Congressional Record (Bound Edition), Volume 158 (2012), Part 11]
[Extensions of Remarks]
[Page 14896]
[From the U.S. Government Publishing Office, www.gpo.gov]




                             OVARIAN CANCER

                                 ______
                                 

                            HON. MARTHA ROBY

                               of alabama

                    in the house of representatives

                       Friday, September 21, 2012

  Mrs. ROBY. Mr. Speaker, I rise today in support of House Resolution 
773--the Recalcitrant Cancer Research Act.
  The incredible team at the National Cancer Institute has provided 
extraordinary research that has been vital to our ability to combat 
cancer in all its forms.
  Still, research for the deadliest cancers--called recalcitrant 
cancers--remains only a small portion of the Institute's total funding.
  Recalcitrant cancers are defined by those that average a less than 
fifty percent survival rate beyond five years.
  It's these cancers, which hide in hard-to-detect places, that can be 
the most dangerous for victims and most painful for families.
  I know this to be true, Mr. Speaker, because my dear friend from 
childhood, Mrs. Kathryn Elliot Williams, lost a grueling battle with 
ovarian cancer earlier this year at the young age of 36. Elliot wasn't 
just my friend. She was a loving wife, a nurturing mother, a daughter, 
a sister and a true servant of her Lord and her neighbor.
  After Elliot passed away I came to this floor to memorialize her 
life. But I cannot think of a better way to honor her memory than for 
the Congress to do its part to ensure that more women faced with this 
terrible disease have hope for the future.
  September, Ovarian Cancer Awareness Month, is the most appropriate 
time to remind women young and old of the risks and ensure that 
research for ovarian cancer and other recalcitrant cancers will remain 
a priority for this country.

                          ____________________